User profiles for Sheamini Sivasampu
 | Sheamini SivasampuHead of Centre for Clinical Outcome Research, Institute for Clinical Researchh, National Inis Verified email at crc.gov.my Cited by 983 |
Expert review on global real-world vaccine effectiveness against SARS-CoV-2
…, CH Nghia, A Ong-Lim, S Sivasampu… - Expert review of …, 2022 - Taylor & Francis
Introduction COVID-19 vaccines have been highly effective in reducing morbidity and
mortality during the pandemic. While primary series vaccination rates are generally high in …
mortality during the pandemic. While primary series vaccination rates are generally high in …
[HTML][HTML] Waning COVID-19 vaccine effectiveness for BNT162b2 and CoronaVac in Malaysia: an observational study
…, H Yahaya, KM Peariasamy, S Sivasampu - International Journal of …, 2022 - Elsevier
Objectives We aimed to investigate and compare waning vaccine effectiveness (VE) against
COVID-19 infection, COVID-19 related ICU admission, and COVID-19-related death for …
COVID-19 infection, COVID-19 related ICU admission, and COVID-19-related death for …
[HTML][HTML] Antibiotic prescribing in public and private practice: a cross-sectional study in primary care clinics in Malaysia
Background Antibiotic overuse is driving the emergence of antibiotic resistance worldwide.
Good data on prescribing behaviours of healthcare providers are needed to support …
Good data on prescribing behaviours of healthcare providers are needed to support …
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 …
…, KM Peariasamy, S Sivasampu - Emerging microbes & …, 2022 - Taylor & Francis
Given emerging evidence of immune escape in the SARS-CoV-2 Omicron viral variant, and
its dominance, effectiveness of heterologous and homologous boosting schedules …
its dominance, effectiveness of heterologous and homologous boosting schedules …
[HTML][HTML] PICK-ing Malaysia's epidemic apart: effectiveness of a diverse COVID-19 vaccine portfolio
Malaysia rolled out a diverse portfolio of predominantly three COVID-19 vaccines (AZD1222,
BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine …
BNT162b2, and CoronaVac) beginning 24 February 2021. We evaluated vaccine …
A systematic review of the relationship between household food insecurity and childhood undernutrition
CW Lye, S Sivasampu, T Mahmudiono… - Journal of Public …, 2023 - academic.oup.com
Background This systematic review aims to investigate the association between household
food insecurity (HFIS) and undernutrition in children under 5 years old, thereby informing …
food insecurity (HFIS) and undernutrition in children under 5 years old, thereby informing …
Risk of serious adverse events after the BNT162b2, CoronaVac, and ChAdOx1 vaccines in Malaysia: A self-controlled case series study
…, R Bahari, NN Ibrahim, F Mahmud, S Sivasampu… - Vaccine, 2022 - Elsevier
Background Rapid deployment of COVID-19 vaccines is challenging for safety surveillance,
especially on adverse events of special interest (AESIs) that were not identified during the …
especially on adverse events of special interest (AESIs) that were not identified during the …
[HTML][HTML] Comparative performance of public and private primary care service delivery in Malaysia: an analysis of findings from QUALICOPC
…, MN Kamaliah, P Groenewegen, S Sivasampu - PLoS …, 2022 - journals.plos.org
Introduction Primary care services are essential in achieving universal health coverage and
Malaysia is looking into public-private partnership to overcome resource constraints. The …
Malaysia is looking into public-private partnership to overcome resource constraints. The …
[HTML][HTML] Age, sex and primary care setting differences in patients' perception of community healthcare seeking behaviour towards health services
Introduction Understanding the potential determinants of community healthcare seeking
behaviour helps in improving healthcare utilisation and health outcomes within different …
behaviour helps in improving healthcare utilisation and health outcomes within different …
Assessment of heterologous and homologous boosting with inactivated COVID-19 vaccine at 3 months compared with homologous boosting of BNT162b2 at 6 …
…, H Yahaya, SM Zin, FM Zin, S Sivasampu… - JAMA Network …, 2022 - jamanetwork.com
Importance Evidence for the timing of booster vaccination after completion of BNT162b2 and
CoronaVac primary vaccination is crucial to guide policy recommendations. Objective To …
CoronaVac primary vaccination is crucial to guide policy recommendations. Objective To …